Ozone as Redox Bioregulator in Preventive Medicine: The Molecular and Pharmacological Basis of the Low-Dose Ozone Concept-A Review.
COVID-19
autoimmune disease
innate immune memory
redox bioregulation
rheumatoid arthritis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
received:
15
09
2023
revised:
08
10
2023
accepted:
19
10
2023
medline:
15
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
The best form of prevention against human infection through bacteria, viruses, and other parasites is ozone disinfection of wastewater and drinking water as a highly effective, well-known method. Various preclinical studies showed promising results, which are being revisited and reconsidered in times of pandemics and led to interesting results in recent clinical trials and reports, as presented by the example of protective measures against COVID-19 in particularly vulnerable clinical personnel. The application of ozone in the form of the low-dose concept induces its regulation by interference of ozone or its peroxides into the redox equilibrium of the biological system, which finally results in the restoration of the glutathione equilibrium. The antioxidant system is activated, the immune system is modulated, and thus the defense mechanisms are improved. In patients with rheumatoid arthritis, repeated ozone treatments have led to new findings in "immunomodulation" through ozone. The more effective immune response is discussed as the response of innate immune memory and opens interesting aspects for complementary treatment of autoimmune diseases.
Identifiants
pubmed: 37958730
pii: ijms242115747
doi: 10.3390/ijms242115747
pmc: PMC10650789
pii:
doi:
Substances chimiques
Ozone
66H7ZZK23N
Drinking Water
0
Wastewater
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
BMC Nephrol. 2011 Nov 14;12:61
pubmed: 22081953
Antioxidants (Basel). 2019 Nov 26;8(12):
pubmed: 31779159
Eur Rev Med Pharmacol Sci. 2021 May;25(9):3632-3639
pubmed: 34002840
Trends Pharmacol Sci. 2008 Oct;29(10):520-7
pubmed: 18752857
Int J Mol Sci. 2021 Jul 23;22(15):
pubmed: 34360655
Int J Biol Macromol. 2007 Dec 1;41(5):504-11
pubmed: 17675149
Free Radic Biol Med. 1999 Nov;27(9-10):916-21
pubmed: 10569624
Mediators Inflamm. 2005 Feb 24;2005(1):16-22
pubmed: 15770062
Front Physiol. 2022 Nov 03;13:1029805
pubmed: 36406985
Free Radic Res. 1999 Sep;31(3):191-6
pubmed: 10499775
Eur J Pharmacol. 2017 Sep 15;811:148-154
pubmed: 28623000
Eur Surg Res. 2003 Jan-Feb;35(1):26-34
pubmed: 12566784
Eur J Pharmacol. 2016 Oct 15;789:313-318
pubmed: 27450487
J Appl Toxicol. 2001 Jul-Aug;21(4):297-301
pubmed: 11481663
Mediators Inflamm. 2004 Feb;13(1):13-9
pubmed: 15203559
J Biol Regul Homeost Agents. 1993 Oct-Dec;7(4):133-8
pubmed: 8023701
Redox Biol. 2021 May;41:101867
pubmed: 33657525
Shock. 2006 Jan;25(1):23-9
pubmed: 16369182
Mediators Inflamm. 1998;7(4):289-94
pubmed: 9792340